格隆汇5月14日｜现货白银失守84美元/盎司，日内跌3.95%。

Agonising over what to buy the three-year-old in your life? Our writer enlisted a panel of mini testers to round up the best of the best • The best gifts for two-year-olds Three-year-olds are a unique breed. Growing in confidence and independence daily, they’re no longer toddlers, but they’re still a way off starting school. With both of my children, I’ve found three a funny yet challenging age. My youngest is three and is now determined to do everything by herself, despite not quite being able to, resulting in frequent tantrums. She’s forming new friendships and is full of curiosity and wonder at the world (we get extremely detailed and lengthy descriptions of the tadpoles living in her classroom). Three-year-olds are into just about everything, with the confidence of someone much older – especially anything you put out of reach (my three-year-old just successfully opened several wrapped presents that weren’t for her) – but too much choice can be overwhelming for them. Continue reading...

Ahead of her new album, the singer-songwriter answers your questions on big 90s nights out, financial survival and the time a whole tube carriage serenaded her I’m curious how you found out you could sing , how you developed your voice and what singing means to you? VladimirS I found out I could sing while I was doing experimental theatre in 1989 – it was a cultural crossover between Ukraine and the UK. My biggest fear was singing in public and I wanted to do something I was afraid of, so I turned a Rimbaud poem into what I imagined was a blues song. And I loved it. Afterwards, I met this producer, William Orbit – I was 19 and he was 37 – through one of the women in the play whose husband was the manager of the Pogues. William decided: “She can sing. I will make a star of her.” He hooked me up with a wonderful singing teacher. But I probably will never see myself as a singer. Even last week I was like: “Oh yeah, I guess I am a musician, that’s ended up being what I do.” I still can’t quite get my head around that. When making a new song up, do you have a job to do, or are you inspired? And in which order do the songs come, regarding melody, chords, words? gin007 I get inspired and that’s why I write. I could be walking in nature or having a conversation and it’ll spark something in my head and I’ll make notes. Then I’ll go to the piano or guitar and often if I’ve got something percolating, that will find its way into the chords. So, melody, words and chords often come together at once. Then I do the work, which is the filling it in. The easy part is the la la la, here’s the idea, here’s the shape, here’s the form, and then it’s like: this all came unconsciously, how do I write to that standard consciously? That can be really, really challenging. It can make your skin crawl because it’s hard to write a good song. Continue reading...

A wannabe folk singer’s humdrum life as a shrimp catcher is upended by the arrival of a mysterious American stranger in the Booker-listed tale Seascraper opens with Thomas Flett rising at five in the morning, eating a cooked breakfast made by his mother and pulling on his oilskins. Thomas is 20, though the ache in his bones makes him feel considerably older – a symptom of the hard physical labour of his job. That job is shanking: dredging the seashore for shrimps at low tide using a horsedrawn cart. Thomas does the same work that his grandfather did decades before him and men from the north-west of England have been doing for 500 years. But his heart is no longer in it: the pay is poor and the work is solitary and dull. He dreams of being a folk singer, playing to audiences in pub backrooms and parlours, and, unbeknown to his mother, has been working on some songs. Benjamin Wood’s novel, which spans two days, brims with atmosphere and detail; you can practically smell the fish guts and seaweed as Thomas stands on the beach and picks over the morning’s haul. The audiobook is narrated by Wood, whose gentle and evocative delivery underlines Thomas’s hard-bitten existence and his quiet longing for a different future. Continue reading...

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo

Six years ago interim manager was working for a charity in south London. On Saturday he leads Chelsea out at the FA Cup final As meteoric rises go, Calum McFarlane’s takes some beating. Six years after he and his assistants Harry Hudson and Dan Hogan were working for a south London charity that provides football and education for disadvantaged children, they will lead out Chelsea to face Manchester City in Saturday’s FA Cup final. There have been accusations of cronyism given they have connections to Joe Shields, Chelsea’s co‑head of recruitment, that go back years, to when McFarlane, Hudson and Hogan were at the charity, the Kinetic Foundation, or beyond. But James Fotheringham, Kinetic’s co-founder, is dismissive of that. Continue reading...

美国3月商业库存环比 0.9%，预期 0.9%，前值 0.4%。

Beth Kobliner’s classic tome of financial literacy for Gen X still works today for Gen Z.

Major earnings expected after the bell on Thursday include: Applied Materials ( AMAT ) Virgin Galactic Holdings ( SPCE ) Nu Holdings Ltd. ( NU ) Workhorse Group ( WKHS ) Figma ( FIG ) Other Earnings slated for release after Thursday's close include: AQMS , BAP , BOOT , BTBT , CLPR , CODX , CSAN , CURI , DARE , DEFT , DFLI , DLO , EGAN , ELVA , ETON , FFAI , FWDI , GAMB , GEMI , GLOB , INFQ , INTZ , INUV , KULR , NMAX , NNE , PXLW , RCEL , RUM , SGMO , SSTI , STNE , TMC , UAMY , UMAC , USAS , VATE , VUZI , WPRT , WYY , XOS , YCBD , YSS For Seeking Alpha's full earnings season calendar, click here .

小朋友是否胖胖才夠可愛？ 記者問：「你覺得自己是否肥胖？」 男孩答：「不肥。」 記者再問：「那你覺得自己怎樣？」 男孩回應：「強壯。」 所謂三歲定八十，兒童肥胖的問題，對他們將來長大後的身體健康有很大影響。 中大兒科學系高級講師梁淑芬說：「現在往往如果問家長，為何小朋友在家不多做運動，她說是因為功課太多了，沒時間動了。」 《新聞掏寶》和大家重溫1996年專題。 記者問：「你覺得怎樣？做完辛不辛苦？」 小朋友稱：「不算很辛苦。」 記者說：「很辛苦嗎？看你剛才走得很氣喘、很辛苦。」 小朋友回應：「是很累。」 父母關心子女的成長，或者有父母會擔心子女吃不夠、發育不好，不過現在有很多家長都擔心子女太胖。根據中文大學的調查顯示，目前香港一百萬個六至十六歲的小朋友和年輕人，大約有十四萬人是太肥的。 香港七歲小孩的膽固醇含量，近年的調查發現，更是高踞世界第二位，比美國同齡的兒童高很多。 梁淑芬指出：「這反映了近年來飲食狀況的變化，特別在食物裡面的脂肪含量，是比過去三十年以前，或者上一兩代，是增加了一倍，或者四五十個巴仙以上。可能中國人以往長時間貧窮，吃肉的機會也不多，所以當她富裕後，她很渴望多吃這些食物。本來以為是福氣，誰知吃得多，原來引致這個問題。」 根據中文大學在1993年調查時的標準，藍色部分是正常體重，這個四歲的男孩正常體重是12至18公斤，即是26至40磅左右，超過或低於這個標準就是過肥或過瘦，小女孩的情況亦差不多。 記者問：「你剛才跑步是否很辛苦？」 男孩回應：「對。」 記者再問：「為甚麼？知不知道為甚麼這麼辛苦？」 男孩表示：「我很怕跑到這麼大圈。」 這男孩今年四歲，已經有差不多一百磅，大他兩歲的哥哥都是有一定分量，有120幾磅。媽媽看見他們太胖，帶他們參加由醫院辦的減肥班，他們在這個班中是最重量級的人馬，但沒有因此而自卑。 記者問：「你覺得自己胖嗎？」 男孩說：「胖。」 記者再問：「很肥嗎？」 男孩回應：「一般。」 但明顯看到要他們做某些運動，的確比其他小朋友辛苦，他就連做柔軟度測試，都因為腳太短和肚腩太大而有困難。連其他小朋友打籃球，他也不肯打。 記者問：「你剛才為何不肯打籃球？」 男孩回答：「打籃球好辛苦，我又不夠高。」 點擊觀看節目重溫

新能源汽车市场持续多年的“价格战”偃旗息鼓。近期，继比亚迪之后，多家新能源车企释放调价信号，或直接上调部分车型售价，或逐步缩减终端购车优惠，开启低调的“涨价”试探。 “目前店内主销车型价格都没变，但1万元的终端立减优惠后续可能会取消，购车成本会有所上升。”北京一家蔚来汽车门店内，销售人员告诉记者。比亚迪门店的销售人员表示，近期涨价仅针对部分特殊选装版本车型，基础款车型价格保持稳定。 与此前轰轰烈烈的“价格战”不同，此次车企调价显得格外谨慎，多以小范围、局部车型调整为主，并未出现全品类、大规模的涨价动作。 据不完全统计，近期已有10余家新能源车企公告调整价格、缩减优惠或计划二季度上调价格。比亚迪对旗下部分车型智能驾驶选装包价格上调2000余元，长安启源智能激光版价格上调3000元，小米新一代SU7全系涨价4000元，蔚来、小鹏透露计划二季度上调车型价格。特斯拉、极氪、阿维塔等品牌已收紧金融免息购车政策，购车隐性成本上升。（每经网）

Wirestock has over 700,000 creators on its platform, which supplies photos, videos and 3D content to AI labs.

Your shot at VC access, global visibility, TechCrunch coverage, and $100K equity-free funding is running out. Deadline to apply is May 27. Apply now.

golibtolibov/iStock via Getty Images Nebius ( NBIS ) is adding to its YTD gains of about 99% with another 16% surge on Tuesday morning post-Q1 earnings results. The stock has now made its way from roughly $89 per share at the start of the year to $207 as of Tuesday’s close. YahooFinance Nebius shares have been on a seemingly impenetrable run, up +59% since our last buy call in mid-March and 285% since our upgrade to buy back in July 2025. We last covered the stock post-Nvidia investment news, arguing that while the Nvidia news was priced in, growth would be weighted towards 2H26, and the Q1 earnings call confirmed our expectations. SeekingAlpha Nebius is now by far the hottest neocloud name, leading the rally YTD, now up 136%, followed closely by arch-nemesis CoreWeave ( CRWV ), despite the latter seeing the opposite reaction to print, diving 13% post-Q1 results last week. YCharts The 1Q26 Review For Q1, Nebius reported revenue up almost sevenfold from a year-ago quarter, about 684% Y/Y and +75% Q/Q, to $399M and $2.82 per share on a GAAP basis. It was a clean beat for the quarter against expectations for a loss of $0.70 per share and $388.57M in revenue. In the words of CEO Arkady Volozh, “unprecedented demand” for compute is to thank. Nebius AI cloud revenue surged 841% Y/Y and 82% sequentially, mirroring top-line growth and making up for roughly 98% of total revenue for the quarter at $389.7M. ARR hit $1.92B as of the end of March, up from $1.25B reported for December. The group’s adjusted EBITDA came in at $129.5M, translating to a 13% margin, and a big gain from the $15M reported in Q4 and a $54M loss a year ago. Adjusted net loss, on the other hand, widened from $83.6M in the year-ago quarter to $100.3M, also better than the expected $174M deficit. Nebius reported Q1 operating cash flow of $2.3B, better than a year ago’s negative $184.1M, and holds $9.3B in cash, versus CoreWeave's $3.3B. Nebius 1Q26 The quarter’s strength bodes well against the report we got ...

Saving enough for retirement is only half the battle. You also have to figure out how to make those savings last across a retirement that could last 30 years or more. That's easier said than done. High inflation can create even greater challenges by forcing you to spend more than you expected. This can be devastating in the early days of your retirement. And it could be especially difficult if you rigidly adhere to the traditional advice about how much to withdraw from your retirement savings. Image source: Getty Images. Continue reading

格隆汇5月14日｜据英国金融时报援引多位外交人士透露，沙特阿拉伯已讨论在中东国家与伊朗之间建立互不侵犯条约的想法，这是美以战争结束后如何管控地区紧张局势的会谈的一部分。两位西方外交官称，沙特正考虑将1970年代缓和冷战期间欧洲紧张局势的赫尔辛基协议作为潜在模式。他们认为，预计战后伊朗将被削弱，但仍对邻国构成威胁。他们补充说，互不侵犯条约是正在考虑的众多方案之一。自伊朗战争爆发以来，海湾国家尤其担心，一旦冲突结束，美国在该地区的大规模军事存在缩减，他们的家门口会出现一个伤痕累累、但更加强硬的伊斯兰政权。

一手涨价潮、一手新故事，中芯国际快 “发飙” 了？ FX168

JHVEPhoto Charles Schwab ( SCHW ) daily average trades reached a record 10.3M in April, while client margin loan balances, up 21% from the end of 2025, reached $136.0B, another record, the company said Thursday. Core net new assets, though, dropped 91% M/M to $7.2B from $79.7B in March and rose 167% from $2.7B in April 2025. Schwab ( SCHW ) stock declined 2.0% in premarket trading. The company is also holding its investor day on Thursday. Total client assets of $12.61T grew 7% M/M and 27% Y/Y. April daily average revenue trades rose 1% M/M and 24% Y/Y. The company added 437K new brokerage accounts, up 2% M/M and flat Y/Y. Transactional sweep cash of $467.6B increased 1% M/M and 16% Y/Y. More on Charles Schwab Charles Schwab Is Better Insulated From AI Than Is Feared Charles Schwab: Digital Asset Push, PDT Rule, Cheap The Charles Schwab Corporation 2026 Q1 - Results - Earnings Call Presentation Most and least shorted large-cap financial stocks at the end of April Schwab Trading Activity Index drops in April as retail clients turn cautious

CharlieAJA/iStock via Getty Images STAAR Surgical ( STAA ) shares climbed on Thursday after the company’s better-than-expected Q1 2026 results, which prompted Wedbush Securities to upgrade the medical supplier to Outperform from Neutral, citing a recovery in its China business. The implantable lens maker reported $93.5M in revenue for Q1 with over 100% YoY growth, exceeding the consensus by $14.8M , which analyst Michael Piccolo attributed to stronger-than-expected recovery in its Chinese operations and continuing double-digit expansion in the U.S. While the company refused to issue guidance again, management’s views during the conference call were positive, Piccolo argued, adding that the solid Q1 results suggested STAAR ( STAA ) is positioned to outperform his initial expectations during the rest of the year. That is especially possible as STAA approaches a historical seasonal strength driven by China’s summer high season in Q2/Q3, Piccolo opined. The analyst also raised his price target on the company to $40 from $26 based on increased revenue estimates for FY26, a higher probability for his bull case scenario, and valuation multiples that were raised to reflect those of its high-growth and more mature peers. More on STAAR Surgical STAAR Surgical Company (STAA) Q1 2026 Earnings Call Transcript STAAR Surgical: Q1 Preliminary Revenues Justify Decision To Reject Alcon Bid STAAR Surgical: Despite Promises Of Improvement, Investors Should Stay Cautious STAAR targets about 75% gross margin and $225M 2026 spend as Switzerland plans to supply 100% of China lenses STAAR Surgical Non-GAAP EPS of $0.48 beats by $0.40, revenue of $93.5M beats by $14.78M

Royal Opera House, London As the central couple, SeokJong Baek and Aigul Akhmetshina are dramatically persuasive and expressive in this revival of Richard Jones’s staging that works hard to make Saint-Saëns’ often dramatically inert opera zing “Who wants to hear Samson et Dalila?” asked George Bernard Shaw in a masterfully scathing review of Saint-Saëns’ opera in its 1893 UK premiere. “I respectfully suggest, nobody.” Samson et Dalila’s fortunes since suggest an alternative answer. But the piece remains an odd hybrid of opera and oratorio, held together by the best of its music and the talents of the two principal singers. On the headline-act front, the Royal Opera’s first revival of Richard Jones ’s 2022 production is a triumph. South Korean tenor SeokJong Baek returns as Samson, the role with which he made his acclaimed Covent Garden debut. Where dramatic chemistry with Elīna Garanča, the 2022 Dalila, was evidently in short supply , this revival boasts a role debut from the ever-astonishing young mezzo Aigul Akhmetshina . Fresh from a winning streak of Carmens , Akhmetshina exudes dramatic self-possession and physical ease, her seductive intensity the ideal foil for the tortured awkwardness of Baek’s hero. Continue reading...

quantic69/iStock via Getty Images Since my first BUY report on Precigen ( PGEN ) last summer, the stock is up 156%. Priced at $1.62 and facing an FDA approval decision in August, I argued that an investment was warranted because: PRGN-2012 showed remarkable efficacy and safety, and If approved, the medical establishment and insurers would be quick to jettison the current regime of costly, grim surgeries for its use as the preferred first-line therapy for Recurrent Respiratory Papillomatosis. That wager proved correct. The approval came in early, and Precigen hasn’t missed a beat, moving rapidly to commercialization and gaining both widespread recognition and insurer acceptance for its drug PAPZIMEOS. On May 13 th , the company reported $21.6 million in revenues for 1Q 2026 , beating analyst estimates and management’s own suggestion of $18 million+ in March. GAAP EPS of -.02 also beat by 2 cents. The company also stated that enrollment within the PAPZIMEOS treatment network had jumped to 400+ , up from 300 patients in March and 200 in January. Management expects this figure to accelerate further as physician outreach and awareness efforts expand. Health plan coverage has already expanded to 215 million people in the US, including Medicare and Medicaid. The firm also declared a total of $56.7 million in cash and cash equivalents by March 31 st and re-iterated that the firm will achieve cash flow positive status by the end of this year. Management has set its sights on several objectives this year more broadly: Stated Goals for 2026 (Precigen) Analyst estimates for FY '26 now clock in at $115 million in revenue—way up from $9.7 million for FY '25—with a ten-cent EPS loss (a dramatic improvement from a $1.37 loss last year). Operationally, this company has come a long way in ten months. I expect Wall Street to finally start to notice with this impressive 1Q earnings call. The Company Based in Germantown, MD, Precigen is a clinical-stage biotech focused on therapies for ...

格隆汇5月14日｜水利部党组书记、部长李国英5月14日主持召开部务会议，研究进一步加强水库、水闸、蓄滞洪区运行管理数字孪生建设，水库大坝安全监测管理，蓄滞洪区内非防洪建设项目洪水影响评价管理等工作。会议指出，会议强调，全面强化蓄滞洪区内非防洪建设项目洪水影响评价管理，加快推进蓄滞洪区建设管理三年行动和数字孪生蓄滞洪区建设三年行动，维护蓄滞洪区容积和功能安全，确保在防洪关键时刻发挥关键作用。

As El Niño develops this year, scientists are increasingly confident it could be one of the strongest on record with global consequences, as Simon King explains.

A number of stocks jumped in the afternoon session after worries about a global chip shortage reached parabolic territory driven by AI optimism and strong investor momentum.

A National Portrait for the National Portrait Gallery aims to bring people together in increasingly atomised country Can a collective portrait of Britain hold together a country that feels as if it is splintering apart? That is the quietly radical hope behind Es Devlin’s new installation at the National Portrait Gallery: a living portrait comprised not of monarchs, politicians or celebrities but of thousands of ordinary faces drifting slowly into and out of one another. Continue reading...

This morning a "Potential Dividend Run Alert" went out for Modiv Industrial Inc (NYSE: MDV), at our DividendChannel.com Dividend Alerts service (a free email alerts feature). Let's look at the situation in greater detail, shall we? First of all, what is a "Dividend Run" anyway?

Morsa Images/DigitalVision via Getty Images Thesis Inovio Pharmaceuticals, Inc. ( INO ) has reported a 1Q26 GAAP EPS figure of -$0.28, which actually beat expectations by about $0.07. We saw much lower operating expenses and also some improved cost control. But despite the earnings beat, the company's cash position did decline, now just $37.7 million as of March 31st this year, so that's before the April raise. That cash sum is down from $58.5 million at year-end, so there's a hefty ongoing cash burn with the company advancing toward commercialisation. Now, going into the regulatory decision this October, I would still be hold-rated since the investment case is for the most part dominated by a binary regulatory outcome for INO-3107. And whilst the company has demonstrated some improved cost discipline, there is still a lot of risk here from accelerated approval eligibility. I think this will ultimately depend on FDA interpretation rather than new data, as I'll explain. That being said, I do see an upside case scenario in that approval would unlock a clear commercial opportunity in a rather underpenetrated market. 1Q26 results Inovio just reported 1Q26 financial results this week, and I see the company as still in a bit of a transition period. We're still in heavy R&D investment but moving more towards potential commercialisation. Total operating expenses actually declined pretty meaningfully since last year, now down to $21.9 million from $25.1 million. We can put this down mainly to reductions in both R&D and G&A. More specifically, R&D spending fell to just $14.1 million, with the company scaling back some engineering services, inventory expenses, and also compensation-related costs. So this would suggest a lot tighter prioritisation of their late-stage programs, particularly INO-3107, which we will get to. As for G&A, expenses here also dropped, now just $7.9 million, which would imply much better cost discipline across the organisation. Now, even with these redu...

中国很可能是全球首个面临大规模动力电池退役潮的国家，没有经验可以借鉴，需要摸着石头过河 资料图：科技公司生产车间回收的废旧动力电池。图：IC photo 【财新网】 动力电池回收利用行业主体多、链条长，标准、法规和政策还不够健全完善。当前仍有大量废旧动力电池流入不规范渠道，甚至存在危及环境和安全的违规行为，没有及时得到遏制。在5月13日举行的动力电池回收利用新生态发展大会s，工信部节能与综合利用司司长王鹏指出上述问题。 王鹏称，动力电池回收利用工作长期缺少“上位法”依据，政府部门、行业协会和从业企业都有些无所适从。“动力电池回收不是一件小事，涉及到环保、安全和国家资源保障。”他说，“这三个方面要求我们在法规建设上迈出更大步伐。”

Lifeway Foods ( LWAY ) announced on Thursday that shareholder Danone USA Public Benefit priced a secondary offering of ~3.45M shares at $19.50 per share. The offering is expected to close on May 19, 2026, subject to standard closing conditions. The sale includes only existing shares from Danone, and Lifeway Foods is not issuing any new shares. The company will not receive any proceeds from the offering. Moreover, the company also plans to repurchase around $5M worth of shares in the offering at the same $19.50 price, subject to the offering closing successfully. The stock is trading ~6% lower at ~$25.60. Source: Press Release More on Lifeway Foods Lifeway Foods: Fairly Valued Relative To Growth (Rating Downgrade) Lifeway Foods: A Special Situation Becomes A Growth Story (Rating Upgrade) Lifeway Foods, Inc. (LWAY) Q4 2025 Earnings Call Prepared Remarks Transcript Lifeway Foods beats top-line estimates; reaffirms long-term target Lifeway Foods soars after raising guidance on strong demand trends